Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-117.94	-211.00	-96.82
Graham Fair Price	-29.58	2.30	3.27
PEG	1675.63	1.25	0.07
Price/Book	-22.98	5.35	6.95
Price/Cash Flow	-79.21	35.82	172.28
Prices/Earnings	-39.68	-60.25	-43.13
Price/Sales	-55.32	3.55	7.94
Price/FCF	-79.21	35.82	172.28
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	3.02	0.10	0.10
Operating Margin	72.15	-0.02	-0.08
ROA	35.01	< 0.005	< 0.005
ROE	-0.04	-0.02	44.86
ROIC	-0.06	-0.02	55.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.12	0.02	487.24
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-2.87	0.52	-81.79
EPS QOQ	-6.15	0.48	-92.13
FCF QOQ	-0.63	2.68	324.30
Revenue QOQ	-0.46	0.71	55.08
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	155.09	67.60	-56.41
Days Sales Outstanding (DSO)	110.91	51.50	-53.57
Inventory Turnover	0.58	1.33	129.43
Debt/Capitalization	0.11	0.12	7.27
Quick Ratio	0.61	0.90	46.92
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	3.43	3.26	-5.17
Cash	2.62	4.09	55.84
Capex	-0.02	-0.04	-80.04
Free Cash Flow	0.14	0.49	251.31
Revenue	3.01	4.91	63.48
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.33	1.36	2.17
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.82	55.54	465.62
Naive Interpretation	Member

06 - Financial Health · Weak

Rating